C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones.

Diabet Med 2004;21:810-7

Nesto R

This review describes the mechanisms underlying inflammation in diabetes and the potential for TZDs to alter cardiovascular disease on that basis.